Advertisement

Topics

Search Results for "Hypertrophic Planus"

01:03 EDT 30th April 2017 | BioPortfolio

Matching Channels

Lichen Planus

Hypertrophic Cardiomyopathy

Ventricular Fibrillation VF

Ventricular fibrillation produces uncoordinated quivering of the ventricle with no useful contractions. It causes immediate syncope and death within minutes. Treatment is with cardiopulmonary resusc...

Matching News

Hypertrophic Cardiomyopathy in Afro-Caribbean vs. Caucasians

How does ethnicity impact the clinical profile and outcomes in hypertrophic cardiomyopathy? Heart

Recreational Exercise in Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, defined as unexplained left ventricular hypertrophy, has an estimated prevalence of at least 1 in 500 and is among the most common forms of inherited heart disease. The pa...

Moderate exercise may benefit patients with hypertrophic cardiomyopathy

As one of the most common causes of sudden cardiac death in young people, a diagnosis of hypertrophic cardiomyopathy can push patients into sedentary lifestyles.

Brisk Walking Can Help in Hypertrophic Cardiomyopathy

The study "provides support for a regimen of unsupervised brisk walking 4 to 7 days per week for a minimum of 30 minutes, as a targeted intervention for patients with hypertrophic cardiom...

Moderate Exercise and Oxygen Consumption in Hypertrophic Cardiomyopathy

This randomized clinical trial assesses whether moderate-intensity exercise training, compared with usual activity, improves exercise capacity in adults with hypertrophic cardiomyopathy.

Sirnaomics begins Phase IIa trial of STP705 to treat hypertrophic scar

Biopharmaceutical company Sirnaomics has initiated the Phase IIa trial of its small interfering RNA (siRNA) therapeutic candidate STP705 (Cotsiranib) to treat patients with hypertrophic scar.

Top 3 Emerging Trends Impacting the Global Hypertrophic Cardiomyopathy Therapeutics Market from 2017-2021: Technavio

Friday, April 21st 2017 at 3:43pm UTC LONDON–(BUSINESS WIRE)– Technavio’s latest report on the global hypertrophic cardiomyopathy therapeutics market provides an analysis of the most imp...

[Seminar] Hypertrophic obstructive cardiomyopathy

Hypertrophic obstructive cardiomyopathy is an inherited myocardial disease defined by cardiac hypertrophy (wall thickness ≥15 mm) that is not explained by abnormal loading conditions, and left ventr...

Matching PubMed Articles

Corneal Involvement by Lichen Planus Pigmentosus.

Lichen planus pigmentosus (LPP) is an exclusive form of lichen planus (LP) characterized by pigmentary incontinence in histopathologic slides.

TRPA1 may contribute to the exacerbation of oral lichen planus through Koebner phenomenon.

We would like to congratulate Kun et al. (Kun et al., 2016) for their recent publication entitled: "TRPA1 receptor is upregulated in human oral lichen planus". This article is very informative and e...

The efficacy of Aloe Vera in management of oral lichen planus: a systematic review and meta-analysis.

The main objective of oral lichen planus management is to control symptomatic outbreaks via eliminating lesions and alleviating symptoms. Corticosteroids; calcineurin inhibitors and most of the availa...

Lichen planus secondary to rabies vaccination.

Lichen planus (LP) is a papulosquamous disease withdistinctive clinical manifestations. The etiology of LPremains unknown. Recently, numerous cases of LPdeveloping after hepatitis B, influenza, and co...

The Magnitude of the Association between Human Papillomavirus and Oral Lichen Planus: A Meta-Analysis.

The role of human papilloma virus (HPV) in oral lichen planus (OLP) is controversial.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement